TCIM
FRTX

TIAA CREF Investment Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

TIAA CREF Investment Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-100
Closed -$406K – 3190
2014
Q1 		$406K Hold
100
– – ﹤0.01% 2997
2013
Q4 		$371K Hold
100
– – ﹤0.01% 3021
2013
Q3 		$393K Sell
100
-3
-3% -$22.5K ﹤0.01% 2991
2013
Q2 		$1.02M Buy
+103
New +$1.14M ﹤0.01% 2579

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return

TIAA CREF Investment Management's FRTX Position: Q2 2014 in Review

TIAA CREF Investment Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2014, closing a stake of 100 shares — an estimated $406K sold.

TIAA CREF Investment Management first reported a position in FRTX in Q2 2013 and held it in 4 quarters. The position peaked at $1.02M in Q2 2013. 70 funds tracked by Wall St. Rank hold FRTX as of Q2 2014.

  • TIAA CREF Investment Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • TIAA CREF Investment Management sold 100 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $406K.
  • TIAA CREF Investment Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and held it in 4 quarters.
  • TIAA CREF Investment Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $1.02M in Q2 2013.
  • 70 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2014.

Based on TIAA CREF Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.